MKB Anesthésie: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
MKB Anesthésie
Largest movements
- Cash +€192,188
up €192,188 (+202%), from €95,157 to €287,345
mainly Net result for the year (+€243,221) and Depreciation (+€2,581)
- Receivables within one year +€25,654
up €25,654 (+121%), from €21,138 to €46,792
of which Other amounts receivable: +€23,536
- Deferred charges and accrued income +€23,919
up €23,919 (+27.5%), from €86,823 to €110,742
- Profit (loss) carried forward +€243,221
up €243,221 (+165%), from €146,998 to €390,219
- Gross operating margin +€97,911
up €97,911 (+51.7%), from €189,544 to €287,455
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €211,796 | €454,534 | +€242,738 | +115% |
| Fixed assets | 21/28 | €8,678 | €9,656 | +€977 | +11.3% |
| Tangible fixed assets | 22/27 | €8,678 | €9,656 | +€977 | +11.3% |
| Furniture and vehicles | 24 | €8,678 | €9,656 | +€977 | +11.3% |
| Current assets | 29/58 | €203,118 | €444,879 | +€241,760 | +119% |
| Amounts receivable within one year | 40/41 | €21,138 | €46,792 | +€25,654 | +121% |
| Trade receivables | 40 | €1,408 | €3,526 | +€2,118 | +150% |
| Other amounts receivable | 41 | €19,730 | €43,266 | +€23,536 | +119% |
| Cash at bank and in hand | 54/58 | €95,157 | €287,345 | +€192,188 | +202% |
| Deferred charges and accrued income | 490/1 | €86,823 | €110,742 | +€23,919 | +27.5% |
| Total equity and liabilities | 10/49 | €211,796 | €454,534 | +€242,738 | +115% |
| Equity | 10/15 | €173,942 | €417,163 | +€243,221 | +140% |
| Contributions | 10/11 | €3,000 | €3,000 | = | 0.0% |
| Reserves | 13 | €23,944 | €23,944 | = | 0.0% |
| Distributable reserves | 133 | €23,944 | €23,944 | = | 0.0% |
| Profit (loss) carried forward | 14 | €146,998 | €390,219 | +€243,221 | +165% |
| Amounts payable | 17/49 | €37,854 | €37,371 | -€483 | -1.3% |
| Amounts payable within one year | 42/48 | €37,854 | €37,371 | -€483 | -1.3% |
| Taxes, remuneration and social security | 45 | €37,854 | €37,360 | -€494 | -1.3% |
| Taxes | 450/3 | €37,854 | €37,360 | -€494 | -1.3% |
| Other amounts payable | 47/48 | - | €11 | +€11 | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €611 | €2,581 | +€1,969 | +322% |
| Other operating charges | 640/8 | - | €50 | +€50 | |
| Gross operating margin | 9900 | €189,544 | €287,455 | +€97,911 | +51.7% |
| Operating profit (loss) | 9901 | €188,933 | €284,824 | +€95,892 | +50.8% |
| Financial income | 75/76B | €437 | €931 | +€494 | +113% |
| Recurring financial income | 75 | €437 | €931 | +€494 | +113% |
| Financial charges | 65/66B | €38 | €155 | +€117 | +313% |
| Recurring financial charges | 65 | €38 | €155 | +€117 | +313% |
| Profit (loss) for the period before taxes | 9903 | €189,332 | €285,601 | +€96,269 | +50.8% |
| Income taxes | 67/77 | €42,334 | €42,380 | +€46 | +0.1% |
| Profit (loss) for the period | 9904 | €146,998 | €243,221 | +€96,223 | +65.5% |
| Profit (loss) for the period to be appropriated | 9905 | €146,998 | €243,221 | +€96,223 | +65.5% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 17 October 2026 via checked.be.